Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) appears in 84 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| 5AM Venture Management, LLC | 31 Mar, 2026 | 3,947,913 | 0 | 0.00% | $9,238,116.00 |
| Squadron Capital Management LLC | 31 Mar, 2026 | 3,631,000 | 3,631,000 | 0.00% | $8,496,540.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 2,956,526 | 1,485,112 | 100.93% | $6,918,271.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 2,848,252 | -1,042 | -0.04% | $6,658.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,310,707 | 2,310,707 | 0.00% | $5,407,054.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,938,145 | -945,600 | -32.79% | $4,535,259.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,732,083 | -232,172 | -11.82% | $4,053,074.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 1,484,098 | -176,280 | -10.62% | $3,472,789.00 |
| Opaleye Management Inc. | 31 Mar, 2026 | 1,412,656 | -1,389,156 | -49.58% | $3,305,615.00 |
| Decheng Capital LLC | 31 Mar, 2026 | 1,323,327 | 0 | 0.00% | $3,096,585.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 1,289,822 | 616,693 | 91.62% | $3,018,183.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,269,837 | 19,869 | 1.59% | $2,971,419.00 |
| Ishara Investments LP | 31 Mar, 2026 | 1,230,000 | -90,000 | -6.82% | $2,878,200.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,132,294 | -234,960 | -17.18% | $2,649,568.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Mar, 2026 | 957,420 | 0 | 0.00% | $2,240,363.00 |
| Pfizer Inc | 31 Mar, 2026 | 953,834 | 0 | 0.00% | $2,003,051.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Mar, 2026 | 792,001 | 4,946 | 0.63% | $1,853,282.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 637,116 | 619,645 | 3,546.71% | $1,490,851.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 621,036 | 31,931 | 5.42% | $1,454,005.00 |
| GSA CAPITAL PARTNERS LLP | 31 Mar, 2026 | 620,407 | -549,166 | -46.95% | $1,452.00 |